RT @sanamloghavi@twitter.com

How we honor #BPDCNDay in #hemepath: You’ve got to diagnose it correctly to treat it appropriately! Why is 1/23 #BPDCNDay ?? CD1/23 … get it? 😉
Most common misdiagnosis: AML M0
Typical morphology: hand mirror (red) or pearl necklace (green) blasts #BPDCN #raredisease 1/

🐦🔗: https://twitter.com/sanamloghavi/status/1617547813939810305

RT @doctorpemm@twitter.com

#ASH22 I really appreciated the opportunity to present my talk on #BPDCN today in the well-attended AML session !! 🔥 Thanks 🙏🏾 to all for your support!!! Superb engagement & awesome Q&A from audience !! One key teaching point: #BPDCN has a quite high incidence rate of CNS/CSF+

🐦🔗: https://twitter.com/doctorpemm/status/1602177042774204417

RT @doctorpemm@twitter.com

#ASH22 🤩 Honored to meet up with our @HemeReports@twitter.com team !!! #ExpertsWithinReach | https://www.hemereports.com 🙏🏾 👏🏽 #meded #leusm #BPDCN #MPNSM #lymsm #mmsm #hemepath #pathologists

🐦🔗: https://twitter.com/doctorpemm/status/1602075331380248578

RT @jaltmanmd@twitter.com

Beautiful talk ⁦@doctorpemm@twitter.com⁩ on #BPDCN long term outcomes during #ASH22. ⁦@ASH_hematology@twitter.com⁩

🐦🔗: https://twitter.com/jaltmanmd/status/1602019097553805313

RT @doctorpemm@twitter.com

#ASH22 | @gotoPER@twitter.com @ASH_hematology@twitter.com ASH Friday Satellite Symposium 👉👉👉Dr Q giving an awesome 👏🏽 talk on Future Directions in #BPDCN !!!! 🔥 👏🏽 @ninashah33@twitter.com @DrKrinaPatel@twitter.com @mtmdphd@twitter.com @szusmani@twitter.com @MediHumdani@twitter.com @NitinJainMD@twitter.com @lane_andy@twitter.com @DrMonicaGuzman@twitter.com #leusm #mmsm #bmtsm

🐦🔗: https://twitter.com/doctorpemm/status/1601342924712968193

RT @doctorpemm@twitter.com

#ASH22 Awesome 👏🏽 talk by Dr @Transplant_Doc@twitter.com at our #BPDCN @ASH_hematology@twitter.com Friday Satellite Symposium !!! #leusm #bmtsm @MediHumdani@twitter.com @BldCancerDoc@twitter.com @lane_andy@twitter.com @DrMonicaGuzman@twitter.com @Lymphoma_Doc@twitter.com @DrKrinaPatel@twitter.com @ninashah33@twitter.com

🐦🔗: https://twitter.com/doctorpemm/status/1601350088386785281

RT @doctorpemm@twitter.com

#ASH22 WOW !! 🙌 So amazed & happy & honored to see our first ever ASH Friday Satellite Symposium on #BPDCN becoming a reality like this !!! Thank you 🙏🏾 all for your support in the #hematology community to help us make this happen ! Please join us soon! @ASH_hematology@twitter.com #leusm

🐦🔗: https://twitter.com/doctorpemm/status/1601308795837485057

RT @doctorpemm@twitter.com

Beginning the journey to #ASH22 with some star ⭐️ power from #Houston !! So excited to connect w/ friends & colleagues from around the world 🌍@ASH_hematology@twitter.com see you all soon! @MDAndersonNews@twitter.com #endcancer #leusm #lymsm #CARTcell #ImmunoOnc #MPNSM #BPDCN #AMLsm #Leadership

🐦🔗: https://twitter.com/doctorpemm/status/1600904767605280771

RT @doctorpemm@twitter.com

#ASH22 | Looking forward to seeing all of you at @ASH_hematology@twitter.com in #NOLA next week ! Please follow me for all of the latest updates from #ASH22 | Make sure you take a moment to download the #ASH22 app 👉 it is very helpful ! #MPNSM #BPDCN #leusm #bmtsm #ImmunoOnc #meded 🙏🏾

🐦🔗: https://twitter.com/doctorpemm/status/1599052051798839301

RT @DrHKantarjian@twitter.com

Sharing our new major effort: North American #BPDCN Consortium to highlight increased collaboration & novel patient-based research approaches | Pemmaraju of @MDAndersonNews@twitter.com #Leukemia | https://doi.org/10.1182/blood.2022017865 via @BloodJournal@twitter.com @ASH_hematology@twitter.com
#leusm

🐦🔗: https://twitter.com/DrHKantarjian/status/1597578175927783424